Resumos

Índice de Palavras-chave

Voltar

• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• Y
• X
• Z

&	Topo

β-LACTAMASES     [141-1]

1	Topo

16S RRNA     [202-1]

A	Topo

A. BAUMANNII-CALCOACETICUS     [197-2]

ACINETOBACTER     [127-1], [206-1], [212-1], [220-1]

ACINETOBACTER BAUMANNII     [143-2], [161-1]

ACREMONIUM SP.     [128-1]

AMARANTHACEAE     [150-1]

ANFOTERICINA B     [223-1]

ANTI-INFECTIVE AGENTS     [150-1]

ANTIBACTERIAL     [117-1], [177-2]

ANTIBIOTICOS     [199-1]

ANTIFUNGAL     [181-1], [184-2]

ANTIFUNGAL ACTION     [162-2]

ANTIFUNGAL ACTIVITY     [136-2], [156-1]

ANTIFUNGAL SUSCEPTIBILITY     [163-2], [179-1]

ANTIFUNGALS IN VITRO SUSCEPTIBILITY     [76-2]

ANTIFUNGICO     [128-1]

ANTIFUNGICOS     [168-1]

ANTIMICROBIAL     [143-1]

ANTIMICROBIAL ACTIVITY     [83-1]

ANTIMICROBIAL RESISTANCE     [141-1], [155-1], [191-2]

ANTIMICROBIAL THERAPY FAILURE     [161-1]

ANTIMICROBIALS     [143-2]

ANTIMICROBIANOS     [121-1], [241-1]

ANTISSEPSIA     [173-2]

ASPERGILOSE     [269-1]

ATIVIDADE ANTIBACTERIANA     [246-1]

ATIVIDADE DE FOSFOLIPASE     [115-1]

ATR-FTIR     [74-1]

B	Topo

BACILOS GRAM-NEGATIVOS     [197-1]

BACTERIAL DRUG RESISTANCE     [90-2]

BACTERIAL RESISTANCE     [77-1]

BACTERIAS     [187-2]

BETALACTAMASES     [158-2], [178-1]

BETALACTAMICOS     [158-2]

BIOFILM     [176-1], [181-1]

BIOFILM MACROCOLONY     [155-1]

BIOFILM,     [169-1]

BIOFILME     [115-2]

BIOFILMS     [150-1]

BIOHAZARD     [57-1]

BIOPSIAS     [269-1]

BLACTX-M-59     [192-1]

BLOOD CULTURE     [145-1]

BLOOD CULTURES     [101-1], [159-1]

BLOODSTREAM INFECTION     [143-1]

BLOODSTREAM INFECTIONS     [101-1]

BOVINOS     [194-2]

BRAZILIAN RED PROPOLIS     [191-2]

BROTH MICRODILUTION     [177-2]

BUBALINOS     [194-2]

BURST OXIDATIVO     [223-1]

C	Topo

C. GATTII     [76-2]

C. NEOFORMANS     [76-2]

CANDIDA     [94-1], [94-2], [122-3], [191-2]

CANDIDA ALBICANS     [142-2], [151-1], [163-1], [163-2], [223-1]

CANDIDA GLABRATA     [181-1]

CANDIDA KRUSEI     [162-1]

CANDIDA SPP     [115-2]

CANDIDA SPP.     [136-1]

CANDIDA TROPICALIS     [115-1], [136-2], [162-2]

CANDIDEMIA     [122-3], [163-1]

CAPSULE     [152-1]

CARBAPENEM     [220-1]

CARBAPENEMASE     [212-1]

CARBAPENEMASES     [122-2], [166-1], [180-1]

CARBAPENEMICOS     [227-1]

CHALCONES     [110-1]

CHORISMATE SYNTHASE     [184-2]

CHROMOBLASTOMYCOSIS     [179-1]

CHRONIC MENINGITIS     [182-1]

CIPROFLOXACIN     [161-1]

CIPROFLOXACINA     [121-2]

CLASSIFICAÇAO FILOGENETICA     [178-2]

CLOSTRIDIUM DIFFICILE     [90-1]

COLISTIN     [153-1], [214-1]

COLONIZAÇAO     [111-2]

COMIDA DE RUA     [243-1]

COMPLEXO MYCOBACTERIUM TUBERCULOSIS     [131-1]

CONTAGIOUS DISEASE     [95-2]

CONTAMINAÇAO AMBIENTAL     [197-1]

CRIOPRESERVAÇAO     [201-1]

CROHN'S DISEASE     [90-1]

CRYPTOCOCCUS SPP     [157-1]

CTX-M     [192-2]

CULTURAS DE VIGILANCIA EPIDEMIOLOGICA     [199-1]

CYMBOPOGON     [94-2]

D	Topo

DERMATOFITOS     [168-1]

DIPPING     [173-2]

DIVERSIDADE BACTERIANA     [121-1]

DRUG REPOSITIONING     [156-1]

DTA     [243-1]

E	Topo

E. AEROGENES     [146-1]

E. CLOACAE     [146-1]

E. COLI     [77-1], [178-1], [178-2]

E. FAECALIS     [117-1]

ELUTION     [207-1], [214-1]

ENTEROBACTER     [155-1]

ENTEROBACTER SPP     [175-1]

ENTEROBACTERIACEAE     [95-1], [158-2], [166-1], [214-1]

ENTEROBACTERIAS     [122-2], [180-1]

ENTEROCOCCUS FAECALIS     [154-1]

ENTEROCOCCUS SPP.     [30-1]

ENZIMAS     [94-1]

EPIDEMIOLOGY     [145-1]

ERTAPENEM     [206-2]

ESBL     [174-1], [178-1], [178-2]

ESCHERICHHIA COLI     [208-1]

ESCHERICHIA COLI     [114-1], [174-1]

ESGOTO DOMESTICO     [121-2], [158-2]

ESKAPE     [177-1]

ESSENTIAL OIL     [74-2]

ESTRESSE OSMOTICO     [115-1]

EUGENOL     [74-1], [177-1]

F	Topo

FATORES DE VIRULENCIA     [114-1]

FILTER PAPER     [57-1]

FLUCONAZOL     [223-1]

FONSECAEA SPECIES     [179-1]

FOOD SAFETY     [154-1]

FREQUENCIA     [98-2], [131-1]

FREQUENCY OF THE ST313-TD GENE     [167-1]

FUNGICIDAL EFFECT     [136-1]

FUSARIUM OXYSPORUM     [95-1], [169-1], [169-2]

G	Topo

GALLERIA MELLONELLA     [155-1]

GENES DE RESISTENCIA     [148-1]

GENETIC CONTEXT     [192-1]

GENETIC SIMILARITY     [175-1]

GENEXPERT SYSTEM     [95-2]

GENOMA     [212-1]

GENOTIPAGEM     [133-1]

GENOTYPES     [157-1]

GESTATIONAL AGE     [202-1]

GINGER     [74-2]

GRAM NEGATIVOS     [122-2]

H	Topo

HEAD AND NECK CANCER     [73-1]

HIDROLISE IMIPENEM     [180-1]

HIGIENIZAÇAO     [187-1]

HIV     [194-1]

HOMENS QUE FAZEM SEXO COM HOMENS     [194-1]

HOSPITAL     [187-1]

HOSPITAL HEMODIALYSIS UNITS     [144-1]

HOSPITAL INFECTION     [185-1]

HOSPITAL-ACQUIRED INFECTIONS     [205-1]

HUISTOPATOLOGICO     [269-1]

HUMAN HEMOCYTE     [95-1]

HYDROCEPHALUS     [182-1]

HYDROXYCHALCONES     [117-1]

HYPERICIN     [151-1], [169-1], [169-2]

HYPERVIRULENT     [152-1]

I	Topo

ICU PATIENTS     [185-1]

IDENTIFICAÇAO     [131-1]

IDENTIFICAÇAO DE LEVEDURAS     [201-1]

IMP-1     [220-1]

INDICE HEMOLITICO     [115-1]

INFECÇAO DE CORRENTE SANGUINEA     [122-3]

INFECÇAO NOSOCOMIAL     [111-2]

INFECÇAO URINARIA     [178-1], [178-2]

INFECÇOES BACTERIANAS     [98-2]

INFECÇOES COMUNITARIAS     [243-1]

INFECÇOES URINARIAS     [187-2]

INFLAMMATORY BOWEL DISEASE     [90-1]

INFUSAO     [128-1]

INHIBITION OF HYPHAE     [142-2]

INTENSIVE CARE UNIT     [205-1]

INTRA MACROPHAGE SURVIVAL     [167-1]

INVASION TO CACO-2 CELL     [167-1]

IRAS     [197-2]

ISCR1-ASSOCIATED CLASS 1 INTEGRON     [192-1]

K	Topo

K. PNEUMONIAE     [192-1], [227-1]

K. QUASIPNEUMONIAE     [192-2]

K. VARIICOLA     [192-2]

KLEBSIELLA PNEUMONIAE     [141-1], [176-1], [177-2]

KPC     [176-1], [192-2], [206-2]

KPC CARBAPENEMASE     [95-1]

KPRCP     [227-1]

L	Topo

LACTOBACILLUS PARACASEI     [246-1]

LEVEDURAS     [201-1]

LIOFILIZAÇAO     [201-1]

LMM11 COMPOUND     [136-2], [162-1]

LOURO     [128-1]

M	Topo

M. TUBERCULOSIS     [165-1]

MALDI-TOF     [57-1], [122-3], [157-1]

MAOS     [111-2]

MARINE ALKALOIDS     [142-2]

MASTITE BOVINA     [173-2]

MECONIUM     [202-1]

MENINGITE BACTERIANA     [30-1]

METAL COMPLEXES     [177-2]

METALLO-β-LACTAMASE     [175-1]

METALO-BETA-LACTAMASE     [148-1]

MICOBACTERIAS NAO TUBERCULOSAS     [131-1]

MICRO-ORGANISMOS MULTIDROGA RESISTENTE     [199-1]

MICROBIAL DIVERSITY     [202-1]

MICROBIAL INFECTION     [205-1]

MICROBIAL SENSITIVITY TEST     [90-2]

MICROBIOLOGICAL ANALYSIS FOR HEMODIALYSI     [144-1]

MINAS FRESH CHEESE     [154-1]

MLST     [174-1]

MOLECULAR ASSESSMENT     [154-1]

MOLECULAR DOCKING     [208-1]

MOLECULAR TYPING     [111-1]

MRSA     [191-1]

MUCORMICOSE     [269-1]

MUCOSITE ORAL     [94-1], [94-2]

MULTIDRUG RESISTANCE     [185-1]

MULTIDRUG-RESISTANT BACTERIA     [83-1]

MULTIPLEX-PCR     [191-1]

MULTIRRESISTENCIA     [178-1], [187-1], [187-2], [212-1]

MURINE MODEL     [184-1]

MUTATIONS     [153-1]

MYCOBACTERIUM TUBERCULOSIS     [74-1], [95-2], [110-1]

N	Topo

NDM     [127-1]

NEONATAL     [111-2]

NEONATE     [101-1]

NEONATOLOGIA     [197-2], [220-1]

NEW ANTIFUNGAL     [184-1]

NON-TUBERCULOUS MYCOBACTERIA     [74-2]

O	Topo

OLEO ESSENCIAL     [128-1]

OMPS     [206-2]

ORAL MICROBIOTA     [73-1]

ORAL MUCOSITIS     [73-1]

OXACILLIN     [159-1]

OZONIZED OIL     [136-1]

OZONIZED OILS     [162-2]

P	Topo

PACIENTES HOSPITALIZADOS     [115-2]

PARACOCCIDIOIDOMICOSE     [133-1]

PARACOCCIDIOIDOMYCOSIS     [156-1], [184-1]

PARACOCCIDOIDOMYCOSIS     [184-2]

PATHOGENICAL POTENTIAL     [154-1]

PATOGENICIDADE     [94-1]

PCR     [133-1]

PCR EM TEMPO REAL     [148-1], [269-1]

PCR MULTIPLEX     [180-1]

PCR-RFLP     [76-2]

PEDIATRIA     [220-1]

PENITENTIARY SERVICES     [95-2]

PERSISTENCE     [161-1]

PFGE     [174-1], [178-2]

PHAGOCYTOSIS     [162-1]

PHENYLPROPANOID DERIVATIVES     [177-1]

PHOSPHOLIPASE ACTIVITY     [163-1]

PHOTODYNAMIC THERAPY     [151-1], [169-1], [169-2]

PHYLOGENY     [77-1]

PLANT LECTIN     [83-1]

PLASMIDEO     [127-1]

POLIMIXINAS     [227-1]

POLYMYXIN     [152-1], [185-1], [214-1]

POLYMYXINS     [207-1]

PORINA     [212-1]

PRESERVAÇAO DE FUNGOS     [201-1]

PREVALENCE     [90-1]

PROBIOTICOS     [246-1]

PROPOLIS     [168-1]

PSEUDOMONAS AERUGINOSA     [111-1]

PULMONARY HISTOMORPHOLOGY     [184-1]

Q	Topo

QNR GENE     [208-1]

R	Topo

RALTEGRAVIR     [156-1]

RECA INHIBITORS     [208-1]

RESISTANCE     [143-2], [153-1], [175-1], [206-1], [206-2], [207-1], [214-1]

RESISTANCE PATTERNS     [143-1]

RESISTANT BACTERIA     [177-1]

RESISTENCE     [146-1], [152-1]

RESISTENCIA     [121-1], [121-2], [241-1]

RESISTENCIA AOS ANTIMICROBIANOS     [114-1]

RESISTENCIA ÀS DROGAS     [165-1]

RESISTENCIA BACTERIANA     [30-1], [111-2], [122-2], [127-1], [197-1], [197-2], [199-1], [227-1]

RESISTENCIA MICROBIANA A MEDICAMENTOS     [148-1]

RESPIRATORY TRACT INFECTION     [205-1]

RFLP     [133-1]

RIO     [121-1]

S	Topo

S. AUREUS     [117-1]

SALMONELLA DUBLIN     [167-1]

SCANNING ELECTRON MICROSCOPY     [184-2]

SCN     [173-2]

SIFILIS     [194-1]

SOS RESPONSE     [208-1]

SPOROTHRIX BRASILIENSIS     [182-1]

SPOROTRICHOSIS     [182-1]

STAPHYLOCOCCUS     [187-1]

STAPHYLOCOCCUS AUREUS     [191-1]

STAPHYLOCOCCUS COAGULASE NEGATIVE     [159-1]

STREPTOCOCCUS MUTANS     [246-1]

SUSCEPTIBILIDADE     [94-2]

SUSCEPTIBILITY     [159-1]

SYNERGISTIC ACTIVITY     [83-1]

SYNTHETIC COMPOUNDS     [142-2]

SYSTEMIC MYCOSES     [156-1]

T	Topo

TB CONTROL     [95-2]

TESTE DE SENSIBILIDADE AOS ANTIMICROBIAN     [165-1]

TESTE FENOTIPICO     [122-2]

TESTES FENOTIPICOS     [166-1]

TREATED WATER     [144-1]

TUBERCULOSE     [165-1], [194-2]

TUBERCULOSTATIC     [110-1]

U	Topo

ULCERATIVE COLITIS     [90-1]

ULTRA-SOM     [98-2]

URINARY TRACT INFECTION     [141-1]

URINARY TRACT INFECTIONS     [174-1], [176-1]

URINE     [90-2]

UROCULTURAS     [115-2]

UROCULTURE     [145-1]

UROPATOGENOS     [121-2]

UTI NEONATAL     [197-1]

V	Topo

VANCOMYCIN     [159-1]

VIGILANCIA     [241-1]

VIRULENCE     [111-1], [176-1], [191-1]

VIRULENCE FACTOR     [142-2]

VIRULENCE FACTORS     [77-1], [146-1], [163-1]

VITEK MS     [157-1]

VULVOVAGINAL CANDIDIASIS     [163-2], [191-2]